France 3D Imaging Market Analysis Report 2022 to 2030

France 3D Imaging Market Analysis

$ 3999

France's 3D imaging market is projected to grow from $0.84 Bn in 2022 to $2.65 Bn by 2030, registering a CAGR of 15.5% during the forecast period of 2022-30. The market will be driven by improved patient outcomes owing to technological advancements and decreased healthcare expenses. The market is segmented by product, application, end-user & portability. Some major players include GE Healthcare, Siemens Healthineers & EOS Imaging.

ID: IN10FRDH001 CATEGORY: Digital Health GEOGRAPHY: France AUTHOR: Vidhi Upadhyay

Buy Now

France 3D Imaging Market Executive Summary

France's 3D imaging market is projected to grow from $0.84 Bn in 2022 to $2.65 Bn by 2030, registering a CAGR of 15.5% during the forecast period of 2022-30. France's healthcare spending for 2019 was $4,492 (11.6%), a 3.56% decline from 2018 and dropping even further in 2020 owing to the COVID- 10 pandemic. According to the French Institute for Patient Experience, 73.6 million imaging operations were performed in France in 2019. As of 2023, the number of people infected by the coronavirus (COVID-19) in France was 39,331,022.

In France, 3D imaging is a fast-emerging sector that is increasingly being employed in diagnosing and treating various medical disorders. This imaging technique creates highly detailed, three-dimensional pictures of the human body using modern technologies such as Computed Tomography (CT), Magnetic Resonance Imaging (MRI), and ultrasound. 3D healthcare imaging is widely available in major cities and healthcare centers throughout France and is conducted by highly qualified medical personnel. These scans may be used to diagnose and monitor a variety of illnesses, including cancer, heart disease, and musculoskeletal issues. Furthermore, 3D imaging is being employed in minimally invasive surgery, allowing surgeons to plan and conduct treatments more accurately and safely. This has resulted in better patient outcomes, shorter hospital stays, and quicker recovery time in France.

france 3D imaging market analysis

Market Dynamics

Market Growth Drivers

The French market is largely influenced by the increased prevalence of musculoskeletal illnesses, strategic initiatives implemented by major corporations such as product launches, and rising healthcare spending. Medical imaging software and hardware have advanced dramatically. As a result, the software produces more precise and detailed pictures, increasing demand for 3D medical imaging in the French region. This has resulted in improved patient outcomes and decreased healthcare expenses. 3D imaging is also becoming increasingly significant in the field of minimally invasive surgery, and the French government has contributed financing for research and development in this area. With the aging of the French population, the need for healthcare services, particularly 3D imaging, is likely to rise. All of these elements are contributing to the expansion and acceptance of 3D imaging in France, and it is projected to play an increasingly important role in the French healthcare system in the future.

Market Restraints

3D imaging technology can be costly and not widely available in some parts of France, resulting in a scarcity of skilled staff to operate and maintain the equipment. Patients and healthcare professionals may be hesitant to employ this technology due to privacy concerns and reimbursement challenges. Furthermore, the restricted availability of 3D imaging in remote locations might limit access for patients. It is critical for the French government and healthcare business to overcome these concerns in order to assure universal availability and accessibility of 3D imaging in France.

Competitive Landscape

Key Players

GE Healthcare
Siemens Healthineers
Philips Healthcare
Toshiba Medical Systems
Cairn Research (FRA)
EOS Imaging (FRA)
eCential Robotics (FRA)

Notable Deals

January 2023, GE HealthCare has agreed to acquire IMACTIS (Grenoble, France), a pioneer in the rapidly expanding field of CT interventional guiding across a wide range of treatment areas
November 2022, GE Healthcare, and MediView XR, Inc., a leading clinical augmented reality med-tech company, revealed their collaboration to incorporate imaging techniques into mixed reality solutions via the OmnifyXRTM Interventional Suite System

Healthcare Policies and Regulatory Landscape

Agence Nationale de Sécurité du Médicament and des Produits de Santé (ANSM) is in charge of medical device and product regulatory monitoring, including 3D imaging systems. Before these systems are sold and utilized in France, ANSM checks that they fulfill safety and performance criteria.

Haute Autorité de Santé (HAS) is in charge of assessing the clinical and cost-effectiveness of healthcare technology like 3D imaging systems. HAS makes recommendations on the use of these technologies in France to healthcare practitioners, consumers, and the government.

Reimbursement Scenario

The Institut national d'assurance maladie-invalidité (INAMI) is in charge of overseeing and funding France's national health insurance system. INAMI decides on the coverage of healthcare technology, including 3D imaging equipment, under the national health insurance policy.

1. Executive Summary
1.1 Digital Health Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Digital Health Policy in Country
1.6 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

France 3D Imaging Market Segmentation

By Product (Revenue, USD Billion):

The 3D Imaging Market is divided majorly into X-ray Imaging Systems, Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Ultrasound & Nuclear Imaging Systems. X-ray Imaging systems have the highest market share in the 3D Imaging market. 3D X- rays are mostly utilized for dental and orthopedic applications. 3D Ultrasound is majorly helpful in tracking the dynamic motion of arteries, and veins and also has applications for various fetal, cardiac, obstetric, and rectal examinations, and many more. The ultrasound segment is predicted to develop substantially over the forecast period, primarily to the advancements in technology in the healthcare industry and the several advantages given by 3D ultrasound imaging over standard ultrasound imaging.

X-ray Imaging Systems
Computed Tomography (CT)
Magnetic Resonance Imaging (MRI)
Ultrasound
Nuclear Imaging systems

By Application (Revenue, USD Billion):

The market for 3D Imaging has applications covering Cardiology, Neurology, Orthopaedics, Gynaecology, Oncology, and other areas of diagnostics as well. Cardiovascular diseases are the leading cause of death globally. The second biggest cause is cancers because of which Oncology holds the highest market share in the 3D Imaging market followed by cardiology as 3D imaging is highly utilized in these two segments for diagnostics and treatments of the same. Neurosurgeons desire three-dimensional (3D) imagery of intracranial tumors, neural structures, skulls, and veins to establish a clear visual image of the surgical field's anatomical orientation prior to surgical intervention aiding better surgical outcomes for patients. Obstetricians employ 3D ultrasound scans to see the gestational sac, pinpoint the location of an ectopic pregnancy, and evaluate for fetal deformities of the face, spine, limbs, and heart. 3D Imaging applications for gynecology are yet in evolving stage and have a great scope for expansion allowing feasible and quick patient care.

Cardiology
Neurology
Orthopedics
Gynecology
Oncology
Others (Urology, etc.)

By End User (Revenue, USD Billion):

Hospitals, Diagnostic Imaging Centers, and other end-user such as private clinics make up the segments of the 3D Imaging Market. The hospitals among these hold the biggest market share due to the increased uptake of cutting-edge medical technology, the expansion of existing 3D Imaging facilities, the rising affordability of 3D Imaging services, the rising prevalence of chronic conditions such as cardiovascular diseases, cancers, respiratory diseases which lead to rising in demand for precise and quick diagnostic and treatment options. Diagnostic Imaging Centers have also been deploying 3D Imaging equipment to improve their standard of care.

Hospitals
Diagnostic Imaging Centers
Other End Users

By Portability (Revenue, USD Billion):

The 3D Imaging market is divided into two segments Stationary & Mobile, considering the portability of the device. Stationary 3D imaging involves equipment that is installed at a particular location and is operated from the same location of installment whereas mobile ones can be relatively smaller in size and hence moved to the patients who are unable to locate the Imaging room. Mobile MRI, Ultrasound, X–ray & CT allow cutting-edge healthcare to be delivered to nearly any location and are yet in the developing stages of expansion.

Stationary
Mobile

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.